Pharmaceutical preparation for the treatment of arthritis; anti-interleukin-6 (il-6) receptor monoclonal antibody for the treatment of disease caused by il-6 production; pharmaceutical preparations for the treatment of cytokine release syndrome; pharmaceutical preparations for the treatment of systemic sclerosis-associated interstitial lung disease